Actinium Pharmaceuticals, Inc. (ATNM)
1.33
+0.02
(+1.53%)
USD |
NYAM |
Jan 16, 16:00
1.36
+0.03
(+2.26%)
After-Hours: 20:00
Actinium Pharmaceuticals EPS Diluted (Quarterly): -0.1645 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Assertio Holdings, Inc. | 1.612 |
| Altimmune, Inc. | -0.2126 |
| Aldeyra Therapeutics, Inc. | -0.1279 |
| Avanos Medical, Inc. | -0.0302 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.131M |
| Revenue (Quarterly) | 0.09M |
| Total Expenses (Quarterly) | 5.221M |
| Enterprise Value | -10.76M |
| Gross Profit Margin (Quarterly) | -128.9% |
| Profit Margin (Quarterly) | -5.70K% |
| Earnings Yield | -83.39% |
| Normalized Earnings Yield | -83.39 |